BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8358157)

  • 1. Fibronectin expression in cancer tissues from patients undergoing radiation therapy.
    Nishioka A; Ogawa Y; Inomata T; Maeda T; Seguchi H
    Histol Histopathol; 1993 Jul; 8(3):457-62. PubMed ID: 8358157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study of fibronectin expression in cancer tissue before and after irradiation].
    Nishioka A; Ogawa Y; Inomata T; Maeda T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Sep; 51(9):1087-97. PubMed ID: 1945790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the immunohistochemical method as predictive assay in radiotherapy of squamous cell carcinoma].
    Ogawa Y; Inomata T; Maeda T; Seguchi H; Nishioka A; Terashima M; Kishimoto S; Saito H; Hirota S; Osaki T
    Gan No Rinsho; 1988 Oct; 34(13):1799-810. PubMed ID: 3264351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of p53 expression in cancer tissues from patients undergoing radiation therapy.
    Hamada N; Ogawa Y; Seguchi H; Terashima M; Nishioka A; Inomata T; Yoshida S; Kishimoto S; Saito H
    Histol Histopathol; 1995 Jul; 10(3):611-7. PubMed ID: 7579809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
    Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
    Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
    Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
    APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
    Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
    Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
    Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
    Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of tissue array technology in head and neck squamous cell carcinoma.
    Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
    Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
    Vural E; Alexiou M; Hunt J; Korourian S; Hanna E
    Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.